Europe Nucleic Acid Labelling Market By Product, Application and End User l Industry Analysis 2021
The Europe Nucleic Acid Labelling Market was worth $359.27 million in 2016 and estimated to be growing at a CAGR of 8.25%, to reach $534.02 million by 2021
Browse report details @ http://www.marketdataforecast.com/market-reports/europe-nucleic-acid-labelling-market-2933/
Our genetic information is carried forward to next generation by nucleic acids which are large complex molecules. Two major type of them are DNA and RNA. They are labelled with tags which help in detection and purification. One of the labelling techniques is Random Priming. A marked counterpart is synthesized on denatured (single-stranded) DNA using short primers as the starting point. Due to the short strands to be synthesized, this system is very simple and fast. Labelling has numerous applications in drug discovery and disease identification.
Major factors accountable for the growth of market are increasing demand for personalized healthcare, increasing expenditure for health care, increasing funding for R&D in genomics and disease diagnosis. Yet, factors like expensive processing techniques and lack of skilled professionals are likely to confine the growth of market.
The Europe Nucleic Acid Labelling market is segmented based on Product, Labelling Technique, Application and End-User. Based on Product the market segmented based on Reagents & Kits and Services. Based on Labelling Technique – PCR, Nick Translation, Random Primer, In-Vitro Transcription, Reverse Transcription. Based on Application – DNA Sequencing, PCR, Fluorescence in Situ Hybridization (FISH), Microarrays, Blotting, In-Situ Hybridization. Based on End-Users – Diagnostic Centres, Research Centres, Hospitals.
Request Free Sample Market Brochure of the report @ http://www.marketdataforecast.com/market-reports/europe-nucleic-acid-labelling-market-2933/request-sample
Based on Geographical analysis the market is separated into regions of U.K., Germany, France, Italy and Spain. U.K. is leading the market while Germany is at second place. Increasing personalized medicines, identifying the genetic modifications and therapeutic areas have enabled U.K. to dominate the market. Germany is expected to grow the fastest due to government initiatives to develop healthcare infrastructure and making the products cost efficient and increased R&D expenditure. DNA sequencing occupies major share in terms of Applications due to its uses in identification of genetic disorders, tumour genetic variations. Reagents and Kits occupy major share among products segment due to their numerous uses in Diagnostic and Research Centres. Based on End User Research Centres occupy the major share owing to increasing government funding to increase research activity and drug discovery.
Some of the key players dominating this market include Thermo Fisher Scientific, New England Biolabs, PerkinElmer, F. Hoffmann La-Roche AG, General Electric Company, Merck KGaA, Enzo Biochem, Promega Corporation, Vector Laboratories, and Agilent Technologies.
Make an Inquiry before buying @ http://www.marketdataforecast.com/market-reports/europe-nucleic-acid-labelling-market-2933/inquire
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Contact Information:
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results